Krystal Biotech, Inc.
DE ˙ DB ˙ US5011471027
257,90 € ↓ -1,10 (-0,42%)
2026-06-04
CENA AKCJI
SecurityDE:4KB / Krystal Biotech, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in 4KB / Krystal Biotech, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Krystal Biotech, Inc. (DE:4KB). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-07-10 , Vanguard Group Inc had reported owning 2,869,136 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 2,869,136 0 -100.00 0.00 -100.00
2024-07-10 2024-07-10 13G/A 2,435,774 2,869,136 17.79 10.05 16.32
2024-02-13 2024-02-13 13G 2,435,774 8.64

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 2,778,845 -13,363 -0.48 685,096 38.99 0.0099
2025-11-07 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 2,792,208 -30,680 -1.09 492,908 27.03 0.0074
2025-08-11 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 2,822,888 -2,394 -0.08 388,034 -23.82 0.0063
2025-05-09 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 2,825,282 -53,169 -1.85 509,398 12.96 0.0092
2025-02-11 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 2,878,451 28,707 1.01 450,938 -13.07 0.0079
2024-11-13 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 2,849,744 -19,392 -0.68 518,739 -1.55 0.0093
2024-08-13 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 2,869,136 436,357 17.94 526,888 21.72 0.0101
2024-05-10 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 2,432,779 -2,995 -0.12 432,864 43.25 0.0086
2024-03-11 2023-12-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,435,774 35,632 1.48 302,182 8.54 0.0066
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 2,435,774 35,632 302,182 0.0057
2023-12-18 2023-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,400,142 693,852 40.66 278,416 38.99 0.0068
2023-11-14 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 2,400,142 693,852 278,416 0.0012
2023-08-14 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 1,706,290 504,060 41.93 200,318 108.12 0.0047
2023-07-14 2023-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,202,230 14,120 1.19 96,251 2.26 0.0025
2023-05-15 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 1,202,230 14,120 96,251 0.0005
2023-02-10 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 1,188,110 91,978 8.39 94,122 23.20 0.0026
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 1,096,132 26,844 2.51 76,400 8.82 0.0022
2022-08-12 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 1,069,288 17,843 1.70 70,210 0.35 0.0020
2022-05-13 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 1,051,445 27,835 2.72 69,964 -2.29 0.0017
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 1,023,610 134,952 15.19 71,602 54.33 0.0016
2021-11-12 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 888,658 42,303 5.00 46,396 -19.38 0.0012
2021-08-13 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 846,355 15,944 1.92 57,552 -10.04 0.0014
2021-05-14 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 830,411 91,273 12.35 63,975 44.26 0.0017
2021-02-12 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 739,138 6,100 0.83 44,347 40.53 0.0013
2020-11-16 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 733,038 8,385 1.16 31,557 5.14 0.0010
2020-08-14 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 724,653 86,605 13.57 30,015 8.79 0.0011
2020-05-15 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 638,048 23,414 3.81 27,589 -18.95 0.0012
2020-02-14 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 614,634 19,290 3.24 34,038 64.64 0.0012
2019-11-14 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 595,344 98,465 19.82 20,674 3.32 0.0008
2019-08-14 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 496,879 143,409 40.57 20,009 72.06 0.0008
2019-05-15 2019-03-31 13F KRYSTAL BIOTECH COM 501147102 353,470 16,705 4.96 11,629 66.18 0.0005
2019-02-14 2018-12-31 13F KRYSTAL BIOTECH COM 501147102 336,765 163,287 94.13 6,998 129.44 0.0003
2018-12-13 2018-09-30 13F/A-2 KRYSTAL BIOTECH COM 501147102 173,478 20,100 13.10 3,050 33.71 0.0001
2018-11-23 2018-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 173,478 0 3,050 0.0001
2018-11-14 2018-09-30 13F KRYSTAL BIOTECH COM 501147102 173,478 20,100 3,050
2018-08-14 2018-06-30 13F KRYSTAL BIOTECH COM 501147102 153,378 4,269 2.86 2,281 51.56 0.0001
2018-05-15 2018-03-31 13F KRYSTAL BIOTECH COM 501147102 149,109 75,009 101.23 1,505 93.20 0.0001
2018-02-14 2017-12-31 13F KRYSTAL BIOTECH COM 501147102 74,100 74,100 779 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.